Zhejiang Orient Gene Biotech Co., Ltd. logo

Zhejiang Orient Gene Biotech Co., Ltd. (688298)

Market Closed
10 Aug, 06:57
SSE SSE
¥
19. 72
+0.35
+1.8069%
¥
6.05B Market Cap
- P/E Ratio
8% Div Yield
1.85M Volume
- Eps
¥ 19.37
Previous Close
Add Transaction
Day Range
19.18 19.84
Year Range
17.03 30.6
Want to track 688298 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688298 closed yesterday higher at ¥19.72, an increase of 1.8069% from Friday's close, completing a monthly increase of 11.036% or ¥1.96. Over the past 12 months, 688298 stock lost -15.942%.
688298 is not paying dividends to its shareholders.
The last earnings report, released on May 22, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zhejiang Orient Gene Biotech Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jun 26, 2023.
The company's stock is traded on one exchange.

688298 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Zhejiang Orient Gene Biotech Co., Ltd. (688298) FAQ

What is the stock price today?

The current price is ¥19.72.

On which exchange is it traded?

Zhejiang Orient Gene Biotech Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688298.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 8%.

What is its market cap?

As of today, the market cap is 6.05B.

Has Zhejiang Orient Gene Biotech Co., Ltd. ever had a stock split?

Zhejiang Orient Gene Biotech Co., Ltd. had 2 splits and the recent split was on Jun 26, 2023.

Zhejiang Orient Gene Biotech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Xiaoliang Fang CEO
SSE Exchange
CNE100003RM8 ISIN
CN Country
2,231 Employees
26 Jun 2023 Last Dividend
26 Jun 2023 Last Split
- IPO Date

Overview

Zhejiang Orient Gene Biotech Co., Ltd., established in 2005 and headquartered in Huzhou, China, is a prestigious enterprise in the biotechnology industry specializing in the research, development, production, and distribution of in vitro diagnostic products on a global scale. The company is recognized for its comprehensive range of diagnostic solutions catering to various healthcare needs, including infectious diseases, drug testing, and fertility assessments.

Products and Services

Zhejiang Orient Gene Biotech offers a wide array of diagnostic products and services, segmented into distinct categories to meet diverse market demands:

  • IFA Solutions, Digital Test, Oral Fluid Test, and COVID-19 Test Products: These diagnostic tools are designed for the detection of infectious diseases and the SARS-CoV-2 virus using immunofluorescence assay (IFA) technology, digital platforms, and oral fluid samples.
  • Immunological Diagnosis Products: The company provides a variety of products for the detection of drugs in hair and saliva, multiplex drug screening in urine, and single-drug tests. Rapid tests for pregnancy, male fertility, and menopause are also available, alongside other specialized diagnostic tests.
  • Molecular Diagnosis Products: This category includes technologically advanced solutions for gene and RNA/DNA analysis, such as nucleic acid extraction systems, real-time PCR systems, and kits for virus detection and viral nucleic acid extraction.
  • Liquid Biochip Products: These products represent a cutting-edge approach to diagnostics, offering high-throughput and precise analysis capabilities.
  • Immunofluorescence and Colloidal Gold Test Readers: Orient Gene offers a range of instruments for reading and interpreting results from immunofluorescence assays and colloidal gold tests, including mini analyzers, handheld readers, and urine drug test cup readers.
  • Dry Biochemical Strips: This product line includes urine reagent strips and analyzers, alcohol tests, and vaginal pH test kits for easy and rapid diagnostic assessments.
  • Raw Materials for Diagnostic Manufacturing: The company also supplies raw materials for various diagnostic applications, including fertility, oncology, cardiology, substance abuse, and infectious diseases, alongside pet diagnostics and antibodies.
  • FISH Probes: Orient Gene provides fluorescence in situ hybridization (FISH) probes for detecting chromosomal abnormalities in solid tumors, hematologic diseases, and for chromosome testing, complete with necessary reagents and instruments.

Contact Information

Address: No. 3787, East Yangguang Avenue, Huzhou, China, 313300
Phone: 86 57 2530 3755